Dairy product consumption reduces cardiovascular mortality: results after 8 year follow-up of ELSA-Brasil

Silva, Fernanda Marcelina; Giatti, Luana; Diniz, Maria de Fátima Haueisen Sander; Brant, Luísa Campos Caldeira; Barreto, Sandhi Maria

doi:10.1007/s00394-021-02686-x

Cited by 2 publications

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of these, 14 608 articles were again excluded, because they were irrelevant to the study objective. Finally, the full text of thirty papers were assessed, of them twelve publications were excluded: one reported risk estimates for theoretical substitutions between dairy products and mortality outcomes (39) , two was performed on colorectal cancer (24) and myocardial infarction patients (40) , three were conducted on the same population with the same outcome (5,15,41) , five studies had reported the risk estimates for combination of dairy products, not yogurt separately (23,(42)(43)(44)(45) , and one study had insufficient data (46) . Finally, we considered data from seventeen cohort studies (eighteen publications) (2,(12)(13)(14)16,(18)(19)(20)(21)(22)(25)(26)(27)(28)(47)(48)(49)(50) .…”

Section: Literature Searchmentioning

confidence: 99%

Yogurt consumption and risk of mortality from all causes, CVD and cancer: a comprehensive systematic review and dose–response meta-analysis of cohort studies

Tutunchi

Naghshi

Naemi

et al. 2022

Public Health Nutr.

View full text Add to dashboard Cite

Objectives: To quantify the dose-response relation between yogurt consumption and risk of mortality from all causes, cardiovascular disease (CVD), and cancer. Design: Systematic review and meta-analysis. Setting: We conducted a comprehensive search of PubMed/Medline, ISI Web of Science, and Scopus databases through August 2022 for cohort studies reporting the association of yogurt consumption with mortality from all causes, CVD, and cancer. Summary relative risks and 95% confidence intervals (CIs) were calculated with a random effects model. Participants: 17 cohort studies (18 publications) of 896871 participants with 75791 deaths (14623 from CVD and 20926 from cancer). Results: High intake of yogurt compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.93; 95%CI: 0.89-0.98, I2=47.3%, n= 12 studies) and CVD (0.89; 95% CI: 0.81-0.98, I2 =33.2%, n=11), but not with cancer (0.96; 95% CI: 0.89-1.03, I2 =26.5%, n=12). Each additional serving of yogurt consumption per day was significantly associated with a reduced risk of all-cause (0.93; 95% CI: 0.86-0.99, I2 =63.3%, n=11) and CVD mortality (0.86; 95% CI: 0.77-0.99, I2 =36.6%, n=10). There was evidence of non-linearity between yogurt consumption and risk of all-cause and CVD mortality, and there was no further reduction in risk above 0.5 serving/day. Conclusion: Summarizing earlier cohort studies, we found an inverse association between yogurt consumption and risk of all-cause and CVD mortality; however, there was no significant association between yogurt consumption and risk of cancer mortality.

show abstract